This enrichment was corroborated when we compared the Pan-cancer Analysis of Whole Genomes (PCAWG) HER2+ breast cancer patients of White European descent (n = 22; ~90% of all HER2+) with HER2+ Nigerians (3.2-fold, P = 0.0034). The gene discussed is ERBB2; the disease is breast cancer.